Le Lézard
Classified in: Health
Subject: SLS

Very Strong Performance Across all Business Areas


TOREKOV, Sweden, Feb. 7, 2018 /PRNewswire/ --

Today's report by Nolato for the fourth quarter and year-end 2017 shows continued very strong performance.

Figures for the fourth quarter of 2017:
? Sales increased to SEK 1,926 million (1,352)
? Operating profit (EBITA) rose to SEK 230 million (130)
? The EBITA margin was 11.9% (9.6)
? Profit after tax was SEK 180 million (95)
? Earnings per share increased to SEK 6.84 (3.61)
? Cash flow after investments was SEK 157 million (SEK 135 million excl. acquisitions)
? The Board of Directors proposes an increase in the dividend to SEK 12.50 (10.50) per share

Adjusted for currency, Group sales growth for the quarter was an exceptionally strong 46%.

Integrated Solutions sales doubled to SEK 900 million (448); adjusted for currency, sales increased by an exceptionally strong 112%. Operating profit (EBITA) rose to SEK 116 million (41) and the EBITA margin to a very strong 12.9% (9.2).

"Continued very high launch volumes were delivered in the quarter for the Vaporiser Heating Products (VHP) product area," commented Nolato President and CEO Christer Wahlquist. "It's estimated that end-customer demand and Nolato's delivered volumes in this area will reach an equilibrium in the second half of 2018, roughly at the level of volumes in the fourth quarter of 2017."

Medical Solutions sales rose to SEK 511 million (463), which adjusted for currency is a strong increase of 12%. Operating profit (EBITA) was SEK 68 million (59), with an EBITA margin of 13.3% (12.7).

"Sales increased in both Medical Devices and Pharma Packaging," said Christer Wahlquist. "Most product areas enjoyed good growth."

Industrial Solutions sales increased to SEK 518 million (443); adjusted for currency, sales grew by a strong 17%. Operating profit (EBITA) increased to SEK 52 million (36) and the EBITA margin was 10.0% (8.1).

"Volumes have developed well across almost all product areas, particularly automotive and hygiene," noted Christer Wahlquist.

For the full year 2017, Group sales rose by 51% to SEK 6,720 million (4,447). Operating profit (EBITA) increased to SEK 763 million (457), giving an EBITA margin of 11.4% (10.3).

Nolato's financial position remains good and debt decreased during the year as a result of the strong earnings and positive cash flow. The equity/assets ratio was 45% (47) at year-end, with net financial liabilities of SEK 153 million (408).

The Board of Directors proposes an increase in the dividend to SEK 12.50 (10.50) per share.

The Annual General Meeting will be held on 24 April at 4 p.m. in Grevie, Sweden.

For further information, please contact:
Christer Wahlquist, President and CEO, +46-(0)-705-804848
Per-Ola Holmström, CFO, +46-(0)-705-763340

Nolato is a Swedish group with operations in Europe, Asia and North America. We develop and manufacture products in polymer materials such as plastic, silicone and TPE for leading customers within medical technology, pharmaceuticals, telecom, automotive, hygiene and other selected industrial sectors. Nolato's shares are listed on Nasdaq Stockholm in the Mid Cap segment, where they are included in the Industrials sector.

This information is information that Nolato AB is obliged to publish pursuant to the EU Market Abuse Regulation. The information was issued for publication by the above contact persons on 7 February 2018 at 2.30 p.m. CET.

www.nolato.com

This information was brought to you by Cision http://news.cision.com
http://news.cision.com/nolato/r/very-strong-performance-across-all-business-areas,c2447154

The following files are available for download:

http://mb.cision.com/Main/966/2447154/788566.pdf

The complete report

http://mb.cision.com/Public/966/2447154/8d831d6d6f73b05d.pdf

The release as pdf


These press releases may also interest you

at 04:00
OMRON Healthcare Co., Ltd. based in Muko, Kyoto Prefecture, Japan, announces to be the official sponsor of May Measurement Month (MMM,) a global campaign to raise awareness of blood pressure screening and promote hypertension prevention, detection,...

at 02:48
Today, RaySearch Laboratories AB (publ)  publishes its Annual Report for the financial year 2023. The report is held available on RaySearch's website, under the section Investors.  This information is information that RaySearch Larboratiories AB...

at 02:43
Shareholders of Zinzino AB (publ) are hereby invited to the annual general meeting on Monday, May 27, 2024, at 1:30 PM at the company's premises at Hulda Mellgrens gata 5 in Gothenburg. Registration begins at 1:15 PM. The company aims to webcast the...

at 02:41
Implantica AG (publ), a med-tech company at the forefront of bringing advanced technology into the body, is publishing its annual report for the fiscal year 2023. The annual report is now available on the company's website. "Implantica had a very...

at 02:08
Revenue amounted to ?498.8m (?419.3m), an increase of 18.9% with an organic growth of 14.2%.Operating profit (EBIT) was ?19.0m (?10.7m), an increase of 78.0%, representing an operating margin of 3.8% (2.6%).Net profit amounted to ?6.5m (?2.1m), which...

at 02:00
Amwins Global Risks is delighted to announce Classic Cars and Cotswolds, an auction to raise money for the Matthew Wilson Multiple Myeloma Fund at Blood Cancer UK. The online auction opens today and features Ferraris, Aston Martins, a Rolls Royce, a...



News published on and distributed by: